Clinical Trial Details

Trial ID: L0555
Source ID: IRCT2017011514333N65
Associated Drug: Rosa canina
Title: Investigation of effectiveness of Rosa canina on liver enzymes in patients with nonalcoholic fatty liver
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Non alcoholic fatty liver(NAFLD). <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
Interventions: Intervention 1: The intervention group will receive a 500 mg pill containing dog rose fractions (fraction of Rosa canina, gelatin solution5% and avicel) per day for 8 weeks. Intervention 2: The control group will receive a 500 mg placebo pill containing l
Outcome Measures: Liver enzymes. Timepoint: Baseline, 48 hours after the end of the study (study will take 8 weeks). Method of measurement: Based on the results of blood tests (including ALT and AST).nan
Sponsor/Collaborators: Vice chancellor for research, Kermanshah University of Medical Sciences
Gender: All
Age: 30 years65 years
Phases: Phase 1/Phase 2
Enrollment: 70
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Crossover, Purpose: Treatment, Other design features: Randomization will be done via block randomization.
Start Date: 09/03/2017
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/13996